Iodine India Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 07-07-2024
- Paid Up Capital ₹ 2.50 M
as on 07-07-2024
- Company Age 9 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 5.00 M
as on 07-07-2024
- Revenue 74.59%
(FY 2021)
- Profit 88.52%
(FY 2021)
- Ebitda 198.13%
(FY 2021)
- Net Worth -4.86%
(FY 2021)
- Total Assets 20.25%
(FY 2021)
About Iodine India Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹5.00 M.
Sridevi, Gopkumar Acharya, Vrushabendra Bhyrapurmathad, and One other member serve as directors at the Company.
- CIN/LLPIN
U24297KA2015PTC080569
- Company No.
080569
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 May 2015
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Iodine India Pharmaceuticals Private Limited offer?
Iodine India Pharmaceuticals Private Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Hand Wash, Hand Sanitizer & Disinfectant, Antiseptic Liquid & Cream.
Who are the key members and board of directors at Iodine India Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Jain  | Additional Director | 22-Mar-2016 | Current |
| Sridevi | Director | 27-May-2015 | Current |
| Gopkumar Acharya | Director | 27-May-2015 | Current |
| Vrushabendra Bhyrapurmathad | Additional Director | 22-Mar-2016 | Current |
Financial Performance of Iodine India Pharmaceuticals.
Iodine India Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 74.59% increase. The company also saw a substantial improvement in profitability, with a 88.52% increase in profit. The company's net worth dipped by a decrease of 4.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Iodine India Pharmaceuticals?
In 2021, Iodine India Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gravis Bio Infotech Private LimitedActive 13 years 10 monthsGopkumar Acharya and Vrushabendra Bhyrapurmathad are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of Mysore Creation Date: 16 Oct 2015 | ₹5.00 M | Open |
How Many Employees Work at Iodine India Pharmaceuticals?
Unlock and access historical data on people associated with Iodine India Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Iodine India Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iodine India Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
